Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
yselty save search
ObsEva Announces UK MHRA Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
yselty treatment authorization
ObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
Published: 2022-06-17 (Crawled : 06:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: -1.09%
H: 4.95%
C: -1.1%
yselty treatment authorization
Calix Selects Alianza as Elite Cloud VoIP Partner
Published: 2021-10-14 (Crawled : 13:00) - prnewswire.com
CALX | $29.44 0.89% 0.0% 770K
|
Electronic Technology
|
| O: 1.59%
H: 0.95%
C: 0.6%
ObsEva Presents Clinical Data on Open-Label Pilot Study of Yselty® (linzagolix) for the Treatment of Severe Adenomyosis at ESHRE Virtual 37th Annual Meeting
Published: 2021-06-30 (Crawled : 06:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: 1.66%
H: 0.65%
C: -0.98%
treatment ev linzagolix
ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of Yselty® (linzagolix) for the Treatment of Uterine Fibroids
Published: 2021-05-20 (Crawled : 07:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: 8.83%
H: 0.0%
C: -5.52%
treatment results phase 3 linzagolix
ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
Published: 2021-01-11 (Crawled : 06:03) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.29%
linzagolix program
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.